Inotek Pharmaceuticals News
Most Popular Inotek Pharmaceuticals Story
Inotek gathers $18M as it plots PhII trials
Lexington, MA-based Inotek Pharmaceuticals has closed an $18 million preferred stock financing. New investor Devon Park led the round, with participation from existing investors Rho Ventures, Care Read more...
Latest Headlines
- June 11, 2010
- April 8, 2008
- August 24, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
